Eugene Goldman

1 month ago | jdsupra.com | Eugene Goldman |Paul Helms |Jeff Weinstein

CURRENT SEC ENFORCEMENT REGARDING FDA-RELATED INFORMATIONOn March 12, 2025, the SEC filed suit against three former Allarity Therapeutics, Inc. executives for allegedly scheming to conceal harsh feedback from the FDA regarding Allarity’s flagship cancer drug candidate.

May 29, 2023 | mondaq.com | Denise Burke |Tony Maida |Monica Wallace |Eugene Goldman

As a part of the Consolidated Appropriations Act, 2023 (CAA), Congress passed new exceptions to the Physician Self-Referral Law (Stark Law) and the federal Anti-Kickback Statute (AKS) allowing certain healthcare entities to provide mental health or behavioral health improvement and/or maintenance programs to physicians and other clinicians.

Mar 10, 2023 | natlawreview.com | Eugene Goldman

On March 1, 2023, the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) charged a healthcare executive with insider trading based on material, non-public negative information known to the executive at the time he adopted two Rule 10b5-1 trading plans. (See here and here.) In so doing, the DOJ and SEC alleged that the executive avoided more than $12.7 million in losses by selling shares in advance of the public release of the material information.

Mar 10, 2023 | natlawreview.com | Eugene Goldman

Legal DisclaimerYou are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only.